17-Hydroxyprogesterone

From NuGOwiki

(Redirected from HMDB00374)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

17-Hydroxyprogesterone
2D structure for 17-Hydroxyprogesterone
Chemical Name 17-hydroxy-Pregn-4-ene-3,20-dione
Chemical Formula C21H30O3
CAS Number 68-96-2
Chemical Information HMDB00374
Biochemical Taxonomy

  • Steroids and Steroid Derivatives

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • C21-Steroid Hormone Metabolism

Biofluid Location

  • Blood
  • Saliva

Tissue Location

  • Adrenal Cortex
  • Adrenal Gland
  • Testes
  • Testis
  • Adipose Tissue

Normal Biofluid Concentrations

  • Blood: 0.011 (0.0003-0.023) uM
  • Saliva: <1.00 uM

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Phenylketonuria

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Blood (Phenylketonuria): 0.152 (0.0022- 0.302) uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
It serves as an intermediate in the biosynthesis of hydrocortisone and gonadal steroid hormones. It is derived from progesterone via 17-hydroxylase, a P450c17 enzyme, or from 17-hydroxypregnenolone via 3β-hydroxysteroid dehydrogenase/Δ5-4 isomerase. 17-Hydroxyprogesterone is a natural progestin and in pregnancy increases in the third trimester primarily due to fetal adrenal production. This hormone is primarily produced in the adrenal glands and to some degree in the gonads, specifically the corpus luteum of the ovary. Normal levels are 3-90 ng/dl in children, and in women, 15-70 ng/dl prior to ovulation, and 35-290 ng/dl during the luteal phase. Measurements of levels of 17-hydroxyprogesterone are useful in the evaluation of patients with suspected congenital adrenal hyperplasia as the typical enzymes that are defective, namely 21-hydroxylase and 11β-hydroxylase, lead to a build-up of 17OHP. In contrast, the rare patient with 17α-hydroxylase deficiency will have very low or undetectable levels of 17OHP. 17OHP levels can also be used to measure contribution of progestational activity of the corpus luteum during pregnancy as progesterone but not 17OHP is also contributed by the placenta.

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Phenylketonuria

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines